Raleigh Capital Management Inc. increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 51.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,015 shares of the financial services provider’s stock after acquiring an additional 2,710 shares during the period. Raleigh Capital Management Inc.’s holdings in CME Group were worth $2,367,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. SG Americas Securities LLC increased its holdings in shares of CME Group by 345.2% during the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock valued at $64,965,000 after acquiring an additional 184,459 shares in the last quarter. FLC Capital Advisors bought a new position in CME Group in the 4th quarter worth about $2,122,000. First Bank & Trust bought a new position in CME Group in the 4th quarter worth about $1,325,000. Mn Services Vermogensbeheer B.V. grew its position in CME Group by 2.9% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 140,210 shares of the financial services provider’s stock valued at $38,289,000 after purchasing an additional 3,931 shares during the last quarter. Finally, MOKAN Wealth Management Inc. grew its position in CME Group by 138.8% during the 4th quarter. MOKAN Wealth Management Inc. now owns 7,144 shares of the financial services provider’s stock valued at $1,953,000 after purchasing an additional 4,152 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Insider Activity
In other CME Group news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.30% of the company’s stock.
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s revenue was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.80 earnings per share. On average, equities analysts predict that CME Group Inc. will post 12.28 earnings per share for the current year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.
Wall Street Analyst Weigh In
Several brokerages have issued reports on CME. TD Cowen decreased their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Erste Group Bank cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Weiss Ratings downgraded shares of CME Group from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 25th. Piper Sandler set a $320.00 price objective on shares of CME Group in a report on Wednesday, June 17th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $300.94.
Check Out Our Latest Research Report on CME
CME Group Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
